# Oral Glutamine in Cardiopulmonary Bypass

> **NCT02491931** · NA · COMPLETED · sponsor: **Instituto Mexicano del Seguro Social** · enrollment: 28 (actual)

## Conditions studied

- Ischemic Heart Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Supplement/placebo intake

## Key facts

- **NCT ID:** NCT02491931
- **Lead sponsor:** Instituto Mexicano del Seguro Social
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2023-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02491931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02491931, "Oral Glutamine in Cardiopulmonary Bypass". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02491931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*